New Delhi [India], October 27 (ANI): The increasing pollution levels in Delhi and adjoining areas may contribute to the increase in COVID-19 cases and deaths due to the virus, experts said on Tuesday.
New Delhi [India], October 27 (ANI): Amid claims of various state governments that it would provide free Covid-19 vaccinations, the Union government's expert group on vaccines on Tuesday said that they should wait for a clearer picture to emerge on vaccine prioritisation.
New Delhi [India], October 21 (ANI): After an India Council of Medical Research(ICMR) made an announcement that it may remove plasma therapy from COVID-19 national treatment protocol, Delhi Health Minister Satyendar Jain asked the council to not do so.
New Delhi [India], October 20 (ANI): Convalescent Plasma Therapy may be removed from the national guideline for the treatment of novel coronavirus after an India Council of Medical Research study revealed that it did not help in reducing mortality or slow the progression of Covid-19, the ICM
New Delhi [India], October 20 (ANI): There is a possibility of re-infection, if antibodies reduce in the body of a Covid-19 recovered person in five months time after the recovery, the Indian Council of Medical Research (ICMR) Director-General Dr Balram Bhargava said on Tuesday.
New Delhi [India], October 6 (ANI): There is no benefit of plasma therapy is arresting mortality in moderate to severe cases of Covid-19, Director General of Indian Council of Medical Research, Balram Bhargava said on Tuesday.
New Delhi [India], October 3 (ANI): Following Mahatma Gandhi's philosophy of healthy lifestyle -- "Less is more" and "Health is wealth" especially in the times of crisis will be a prominent way to foster ease of living during the COVID-19 pandemic, said Prof (Dr) Balram Bhargava, Director Ge
New Delhi [India], September 29 (ANI): One in 15 individuals aged 10 years or above were estimated to be exposed to SARS-CoV-2 (coronavirus) by August 2020, according to the findings of India Council of Medical Research (ICMR) second sero-survey, said Dr Balram Bhargava, Director General
New Delhi [India], September 23 (ANI): The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunogenicity and efficacy parameters for pharma giants who are developing COVID-19 vaccines.
New Delhi [India], September 15 (ANI): The Indian Council of Medical Research (ICMR) DG Dr Balram Bhargava said on Tuesday said that re-infection with coronavirus is very rare.
New Delhi [India], September 15 (ANI): The National Task Force on COVID-19 and joint monitoring group (JMG) of the Health Ministry will decide whether the plasma therapy should be continued in the treatment of coronavirus infected patients in India, Professor (Dr.) Balram Bhargava, DG of
New Delhi [India], September 15 (ANI): The result of the second national sero survey will be announced by the end of September, said Professor (Dr.) Balram Bhargava, DG of Indian Council of Medical Research (ICMR) on Tuesday.